← Eichor
Study identifier: NCT07499596 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Morus Nigra Mouthwash on Gingivitis Treatment

Condition: Gingivitis  ·  Sponsor: Inonu University

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The aim of this study is to evaluate the clinical, microbiological, and biochemical effects of Morus nigra (black mulberry) mouthwash when used as an adjunct to non-surgical periodontal treatment (scaling and root planing - SRP) in patients with generalized gingivitis. Participants will be randomly assigned to two groups: one receiving SRP only, and the other receiving SRP plus Morus nigra mouthwash twice daily for 14 days. Clinical parameters, cytokine levels in gingival crevicular fluid (TNF-alpha, IL-1beta, IL-10), and subgingival bacterial load will be assessed at baseline, 1 month, and 3 months.

This description comes directly from the study's public registry record.

Talk to the study team

Omer Alperen Kırmızıgul, Assistant Professor  ·  +905073951987  ·  alperen.kirmizigul@inonu.edu.tr

Burak Koçak, Dds  ·  +9005446609444  ·  kocakburak44@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Inonu University Faculty of DentistryBattalgazi, Malatya, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07499596